Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02144649 · ClinicalTrials.gov registry record · NA
Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT02144649: Completed NA study, sponsored by Ohio State University Comprehensive Cancer Center.
NCT02144649 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02144649, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This randomized pilot clinical trial compares tangerine and red tomato juice in treating patients with prostate cancer undergoing surgery. A diet high in lycopene, a substance found in tomatoes, may help prevent normal cells from transforming into cancer cells in patients with prostate cancer.
Interventions
- OTHER questionnaire administration
- OTHER Correlative studies
- DIETARY_SUPPLEMENT dietary intervention (tangerine tomato juice)
- DIETARY_SUPPLEMENT dietary intervention (red tomato juice)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-09-22 |
| Phase | NA |
What the finished NCT02144649 record still lists
NCT02144649 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 4 interventions - of which questionnaire administration is the first listed.
NCT02144649 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02144649 about?
NCT02144649 is a clinical study titled "Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery". This randomized pilot clinical trial compares tangerine and red tomato juice in treating patients with prostate cancer undergoing surgery. A diet high in lycopene, a substance found in tomatoes, may help prevent normal cells from transforming into cancer cells in patients with prostate cancer.
What is the current status of trial NCT02144649?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2015-06. Estimated completion is 2016-09-22.
What interventions are being tested in trial NCT02144649?
The interventions under investigation include: questionnaire administration (OTHER), Correlative studies (OTHER), dietary intervention (tangerine tomato juice) (DIETARY_SUPPLEMENT), dietary intervention (red tomato juice) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02144649?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02144649's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia